1402 Journal of Natural Products, 2008, Vol. 71, No. 8
Huang et al.
m/z 266 [M]+ (5), 248 (45), 230 (35), 204 (55), 121 (80), 84 (100);
HREIMS m/z 266.1510 (calcd for C15H22O4, 266.1518).
experimentally proving the true biogenetic origin and the effective
biological and ecological role that spirolingshuiolide (12) and related
sesquiterpenes play in the life cycle of the sponge and finally at
confirming their structural peculiarities by synthesis.
Lingshuiperoxide (6): colorless oil; [R]2D0 -7.3 (c 0.41, CHCl3);
1
IR (KBr) νmax 2921, 1745, 1461, 1376 cm-1; H NMR (CDCl3, 400
MHz) 1H NMR (CDCl3, 400 MHz) δ 6.92 (1H, br s, H-10), 6.59 (1H,
dd, J ) 6.1, 8.2 Hz, H-3), 6.39 (1H, br d, J ) 8.2 Hz, H-2), 6.11 (1H,
br s, H-11), 4.33 (1H, m, H-4), 4.11 (1H, br s, OH), 2.38 (1H, m,
H-8b), 2.33 (1H, m, H-8a), 2.29 (1H, m, H-5), 1.99 (1H, m, H-7b),
1.66 (1H, m, H-7a), 1.30 (3H, s, Me-13), 0.83 (3H, s, Me-15), 0.82
(3H, d, J ) 6.6 Hz, Me-14); 13C NMR (CDCl3, 100 MHz) see Table
1; ESIMS m/z 303 [M + Na]+; HRESIMS m/z 303.1209 (calcd for
C15H22O5Na, 303.1208).
It has been discovered that protein tyrosine phosphatase 1B
(PTP1B) is involved both physiologically and pathologically in
regulating the signaling of the insulin receptor. Knockout studies
in mice have shown that PTP1B-deficient mice displayed enhanced
insulin sensitivity and resistance to diet-induced obesity. PTP1B
thus becomes a promising target in the treatment of type-II diabetes
and obesity.19 For this reason, the development of small-molecule
inhibitors of PTP1B has attracted considerable attention in both
academic research and pharmaceutical investigation. In fact, a
number of reports describing natural products as PTP1B inhibitors
have appeared in the past decade.20 In light of this observation, all
the new and known compounds isolated in this study were evaluated
for their inhibitory activity against PTP1B. The bioassay results
showed that compounds 7-9 had moderate inhibitory activities,
with IC50 values of 8.8, 11.6, and 6.8 µg/mL, respectively, while
compound 15 had the strongest PTP1B inhibitory effect, with an
IC50 value of 1.9 µg/mL.
Isodysetherin (10): colorless oil; [R]2D0 +81 (c 0.26, CHCl3); IR
(KBr) νmax 2966, 1776, 1461, 1070 cm-1; 1H NMR (CDCl3, 400 MHz)
δ 5.47 (1H, d, J ) 2.3 Hz, H-13), 5.34 (1H, br s, H-5), 3.60 (1H, d, J
) 2.3 Hz, H-12), 2.85 (1H, m, H-4), 2.09 (1H, dd, J ) 8.2, 14.0 Hz,
H-3R), 1.93 (1H, m, H-3ꢀ), 1.89 (2H, m, H2-7), 1.64 (2H, m, H2-8),
1.66 (1H, m, H-9), 1.64 (3H, s, Me-15), 1.38 (3H, s, Me-10), 1.08
(3H, s, Me-11); 13C NMR (CDCl3, 100 MHz) see Table 1; EIMS m/z
248 [M]+ (50), 233 (35), 203 (50), 135 (45), 119 (100); HREIMS m/z
248.1415 (calcd for C15H20O3, 248.1412).
Spirolingshuiolide (12): colorless oil; [R]2D0 -31 (c 0.16, CHCl3);
1
IR (KBr) νmax 2962, 1772, 1460, 1068 cm-1; H NMR (CDCl3, 400
MHz) δ 5.80 (1H, ddd, J ) 2.4, 4.8, 10.0 Hz, H-2), 5.48 (1H, d, J )
2.2 Hz, H-11), 5.32 (1H, br d, J ) 10.0 Hz, H-1), 3.86 (1H, d, J ) 2.2
Hz, H-12), 2.18 (1H, m, H-7a), 2.02 (1H, m, H-3b), 1.98 (1H, m, H-7b),
1.96 (1H, m, H-6b), 1.94 (1H, m, H-4), 1.82 (1H, m, H-3a), 1.76 (1H,
m, H-6a), 1.03 (3H, s, Me-15), 0.95 (3H, d,J ) 6.6 Hz, Me-14), 0.79
(3H, s, Me-13); 13C NMR (CDCl3, 100 MHz) see Table 1; EIMS m/z
248 [M]+ (5), 219 (20), 203 (25), 121 (100); HREIMS m/z 248.1401
(calcd for C15H20O3, 248.1405).
Preparation of (S)- and (R)-MTPA Ester. The 2S derivative was
obtained by treating 2 (1.5 mg) with (R)-MTPA-Cl in dry pyridine for
ca. 16 h under stirring at RT. The reaction mixture was purified by CC
(silica gel) to afford pure 2S (1.2 mg). In a similar manner, 2R (1.3
mg) was prepared from (S)-MTPA-Cl.
Experimental Section
General Experimental Procedures. Optical rotations were measured
on a Perkin-Elmer 241MC polarimeter. UV spectra were recorded on
a Varian Cary 300 Bio spectrophotometer. IR spectra were recorded
on a Nicolet-Magna FT-IR 750 spectrometer. NMR spectra were
measured on a Bruker DRX-400 spectrometer with the residual CHCl3
(δH 7.26 ppm, δC 77.0 ppm) as an internal standard. EIMS and HREIMS
data were obtained on a Finnigan-MAT-95 mass spectrometer. ESIMS
and HRESIMS spectra were recorded on a Q-TOF Micro LC-MS-
MS mass spectrometer. Reversed-phase HPLC (Agilent 1100 series
liquid chromatography using a VWD G1314A detector at 210 nm and
a semipreparative ODS-HG-5 [5 µm, 10 mm (i.d.) × 25 cm] column)
was also employed. Commercial Si gel (Qing Dao Hai Yang Chemical
Group Co., 200-300 and 400-600 mesh) was used for CC, and
precoated Si gel plates (Yan Tai Zi Fu Chemical Group Co., G60 F-254)
were used for analytical TLC.
Biological Material. The specimens of D. septosa identified by
Professor J.-H. Li of Institute of Oceanology, Chinese Academy of
Sciences, were collected by scuba at Lingshui Bay, Hainan Province,
China, in November 2001, and were frozen immediately after collection.
A voucher sample (SS-38) is available for inspection at the Herbarium
of Shanghai Institute of Materia Medica, CAS.
Extraction and Isolation. The frozen sample (500 g dry weight)
was lyophilized and exhaustively extracted with acetone. The extract
was concentrated in Vacuo, and the resulting residue was extracted with
Et2O and n-BuOH, respectively. The Et2O-soluble portion was repeat-
edly subjected to silica gel column chromatographies (using increasing
concentrations of EtOAc in petroleum ether as the eluent) to give 1
(50.0 mg), 2 (55.0 mg), 6 (4.8 mg), 7 (18.7 mg), 8 (18.7 mg), 9 (18.7
mg), 12 (0.8 mg), 13 (10.9 mg), 14 (10.7 mg), and 15 (41.7 mg),
respectively. The portion eluted with EtOAc/petroleum ether (95:5) was
further purified by semipreparative RP-HPLC (MeOH/H2O, 70:30; 2.5
mL/min; UV 210 nm) to give 10 (1.5 mg, tR ) 37.7 min) and 11 (3.2
mg, tR 38.8 min).
2S: 1H NMR (CDCl3, 400 MHz) δ 7.06 (1H, br s, H-11), 6.81 (1H,
br s, H-10), 5.46 (1H, br s, H-2), 5.53 (1H, m, H-3), 2.26 (1H, m,
H-8b), 1.98 (1H, m, H-8a), 1.85 (1H, m, H-4R), 1.83 (1H, m, H-5),
1.67 (3H, s, Me-13), 1.63 (2H, m, H2-7), 1.51 (1H, m, H-4ꢀ), 0.91
(3H, s, Me-15), 0.89 (3H, d, J ) 6.5 Hz, Me-14).
2R: 1H NMR (CDCl3, 400 MHz) δ 7.06 (1H, br s, H-11), 6.81 (1H,
br s, H-10), 5.33 (1H, br s, H-2), 5.54 (1H, m, H-3), 2.26 (1H, m,
H-8b), 1.98 (1H, m, H-8a), 1.94 (1H, m, H-4R), 1.85 (1H, m, H-5),
1.64 (3H, s, Me-13), 1.62 (2H, m, H2-7), 1.60 (1H, m, H-4ꢀ), 0.91
(3H, s, Me-15), 0.92 (3H, d, J ) 6.5 Hz, Me-14).
Biological Assay. Recombinant PTP1B catalytic domain was
expressed and purified according to a previous report.21 The enzymatic
activities of the PTP1B catalytic domain were determined at 30 °C by
monitoring the hydrolysis of pNPP. Dephosphorylation of pNPP
generates product pNP, which was monitored at an absorbance of 405
nm by the EnVision multilabel plate reader (PerkinElmer Life Sciences,
Boston, MA). In a typical 100 µL assay mixture containing 50 mmol/L
3-[N-morpholino] propanesulfonic acid (MOPs), pH 6.5, 2 mmol/L
pNPP, and 30 nmol/L recombinant PTP1B, activities were continuously
monitored and the initial rate of the hydrolysis was determined using
the early linear region of the enzymatic reaction kinetic curve. The
IC50 was calculated with Prism 4 software (Graphpad, San Diego, CA)
from the nonlinear curve fitting of the percentage of inhibition (%
inhibition) versus the inhibitor concentration [I] by using the following
equation: % Inhibition ) 100/(1 + [IC50/[I]]k), where k is the Hill
coefficient.
Lingshuiolide A (1): colorless oil; [R]2D0 +85.4 (c 0.37, CHCl3); IR
(KBr) νmax 3376, 2968, 1762, 1658, 1444, 1010 cm-1; 1H NMR (CDCl3,
400 MHz) δ 6.85 (1H, br s, H-10), 6.06 (1H, br s, H-11), 5.85 (1H, br
s, H-2), 4.06 (1H, m, H-3), 2.22 (1H, m, H-8b), 1.89 (1H, m, H-8a),
1.82 (1H, m, H-4R), 1.77 (1H, m, H-5), 1.66 (3H, s, Me-13), 1.61
(2H, m, H2-7), 1.39 (1H, m, H-4ꢀ), 0.92 (3H, s, Me-15), 0.90 (3H, d,
J ) 6.5 Hz, Me-14); 13C NMR (CDCl3, 100 MHz) see Table 1; EIMS
m/z 266 [M]+ (5), 248 (10), 203 (10), 128 (36), 121 (100); HREIMS
m/z 266.1532 (calcd for C15H22O4, 266.1518).
Acknowledgment. This research work was financially supported by
the National Marine 863 Projects (Nos. 2006AA09Z447, 2006AA09Z412,
and 2007AA09Z447), the Natural Science Foundation of China (Nos.
30730108, 20721003, and 20772136), STCSM Projects (Nos. 07XD14036
and 06DZ22028), and CAS Key Project (Grant KSCX2-YW-R-18).
Lingshuiolide B (2): colorless oil; [R]2D0 -2.0 (c 0.33, CHCl3); IR
(KBr) νmax 3355, 2964, 1751, 1658, 1446, 1010 cm-1; 1H NMR (CDCl3,
400 MHz) δ 6.82 (1H, br s, H-10), 6.07 (1H, br s, H-11), 5.47 (1H, br
s, H-2), 4.20 (1H, m, H-3), 2.22 (1H, m, H-8b), 1.89 (1H, m, H-8a),
1.82 (1H, m, H-4R), 1.77 (1H, m, H-5), 1.66 (3H, s, Me-13), 1.61
(2H, m, H2-7), 1.39 (1H, m, H-4ꢀ), 0.92 (3H, s, Me-15), 0.90 (3H, d,
J ) 6.5 Hz, Me-14); 13C NMR (CDCl3, 100 MHz) see Table 1; EIMS
Supporting Information Available: 1D and 2D NMR and HREIMS
spectra of compound 12. This information is available free of charge